肤阴洁品牌怎么样 申请店铺

我要投票 肤阴洁在女性洗液行业中的票数:333 更新时间:2025-06-17
肤阴洁是哪个国家的品牌?「肤阴洁」是 广西源安堂药业有限公司 旗下著名品牌。该品牌发源于广西贵港市,由创始人莫董在2001年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力肤阴洁品牌出海!将品牌入驻外推网,定制肤阴洁品牌推广信息,可以显著提高肤阴洁产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

肤阴洁怎么样

具有独立自主知识产权,涵盖OTC/医院/超市等市场板块的诸多产品,集科研/生产/销售/服务于一体的大型中药制药企业


广西源安堂药业有限公司是一个集科研、生产、销售、服务于一体、拥有超亿元固定资产、年生产能力超10亿元规模的广西民族品牌特色药生产企业。

公司行政总部、现代化药品生产基地坐落于广西桂平市中沙镇,公司营销中心及技术研发机构设立在广西首府南宁市。公司现有员工600余人,其中,包括硕士研究生、本科生、大中专生等各类专业技术人才约300余人。

公司成立30年来,结合自身的技术资源和品牌优势,成功研发生产出一系列具有独立自主知识产权的国家新药,投放市场后,产销两旺,丰富了广西民族特色药品的阵营,带来了巨大的社会经济效益。公司主要国药有:肤阴洁®复方黄松洗液、肤阴洁®复方黄松湿巾、源安堂®银胡感冒散、源安堂®肠胃散、源安堂®朱虎化瘀酊等。公司研发生产的几类国药,都是取源于桂东南地道的原生态中药材,精心萃取,科学配伍,各有特色。

经过30多年的锤炼与洗礼,公司各类国药产品,形成了具有“原生态科技创新型”和“市场化品牌实用型”的特点。

肤阴洁®复方黄松洗液和湿巾是公司的支柱产品,自成系列,形成并丰富了涵盖OTC药店销售、医院销售、连锁销售等市场营销体系,在全国近30个省、直辖市、自治区构建起了布局合理的市场营销网络。

源安堂®银胡感冒散、源安堂®肠胃散、源安堂®朱虎化瘀酊是广西乃至全国仅有的民族特色药,显示出独特的疗效。源安堂®银胡感冒散,是以青蒿素为主要成分的创新型国药,广泛应用于小孩、中老年人,其在感冒初期治疗中,成为不打针、不吃药、贴肚脐疗法、治感冒的典范,获得国家发明专利,荣获“世界卫生组织教科文卫部科技发明特别贡献奖”,是广西中成药富有民族特色的药品,在华东、华中、华南市场销售中保持旺盛的势头。源安堂®肠胃散、朱虎化瘀酊等国药产品,在临床实践中各具特色,疗效显著,销售发展潜力很大,具有无限的医药商机和市场价值。

公司发展30多年来,坚持走科技创新、品牌强业的发展道路,努力培育和打造企业核心竞争力,拥有技术发明创造和各项产品商标专利共17项,公司将科技研发成果转化为社会生产力,有利于推动广西社会经济的和谐发展。公司“源安堂”和“肤阴洁”两大品牌的不断推广与发展,为其赋予了丰富的科技内涵和潜在的品牌价值,由于公司国药品牌的影响力、市场销售的增长率和广大消费者的认同感。

广西源安堂药业有限公司将在广西自治区各级党委、政府的正确领导下,在广西食品药品监督管理局和自治区林业厅的精心指导下,结合自身优势,以市场为导向,以研发为动力,以效益为核心,以人为本,苦练内功,加强管理,整合资源,改革创新,励精图治,带动地方经济发展,打造广西民族中药特色品牌,为发展中国中医药和人类健康事业再作贡献。


Guangxi yuanantang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine pharmaceutical enterprise with independent intellectual property rights, covering OTC / hospital / supermarket and other market segments, integrating scientific research / production / sales / service. It is a Guangxi national brand characteristic pharmaceutical manufacturer with fixed assets of more than 100 million yuan and annual production capacity of more than 1 billion yuan 。 The company's administrative headquarters and modern pharmaceutical production base are located in Zhongsha Town, Guiping City, Guangxi Province. The company's marketing center and technical research and development organization are set up in Nanning, the capital city of Guangxi Province. The company has more than 600 employees, including more than 300 professional and technical talents such as master's degree, undergraduate, college and technical secondary school students. In the past 30 years since its establishment, the company has successfully developed and produced a series of national new drugs with independent intellectual property rights in combination with its own technical resources and brand advantages. After being put on the market, the production and marketing of these drugs have flourished, enriching the camp of drugs with national characteristics in Guangxi and bringing huge social and economic benefits. The main Chinese medicines of the company are Fuyinjie (Fuyinjie), Fuyinjie (Fuyinjie), Fuyinjie (Fuyinjie), fuhuangsong (Fuyinjie), yuanantang (Yinhu Ganmao), yuanantang (Changwei), yuanantang (Zhuhu Huayu) tincture, etc. Several kinds of national medicines developed and produced by the company are all original ecological Chinese herbal medicines from the southeast of Guangxi. They are carefully extracted, scientifically combined and have their own characteristics. After more than 30 years of tempering and baptism, all kinds of Chinese medicine products of the company have formed the characteristics of "original ecological technology innovation type" and "market-oriented brand practical type". Fuyinjie ® compound Huangsong lotion and wipes are the pillar products of the company. They have formed and enriched the marketing system covering OTC drugstore sales, hospital sales, chain sales, etc., and established a reasonable marketing network in nearly 30 provinces, municipalities and autonomous regions. Yuanantang Yinhu Ganmao powder, yuanantang Changwei powder and yuanantang Zhuhu Huayu tincture are the only national characteristic drugs in Guangxi and even in China, showing unique curative effect. Yuanantang ® Yinhu Ganmao powder is an innovative national medicine with artemisinin as the main component, which is widely used in children and middle-aged and elderly people. In the early treatment of cold, it has become a model of no injection, no medicine, sticking navel therapy and treating cold. It has won the national invention patent, won the "special contribution award for scientific and technological invention of the Ministry of education, culture and health of the World Health Organization", and is rich in people in Guangxi Traditional Chinese medicine Ethnic medicine has maintained a strong momentum in the marketing of East China, central China and South China. The national medicine products, such as yuanantang ® changweisan and Zhuhu Huayu tincture, have their own characteristics in clinical practice, significant curative effect, great potential for sales and development, and infinite medical business opportunities and market value. Over the past 30 years of development, the company has adhered to the development path of scientific and technological innovation and strong brand industry, made great efforts to cultivate and build the core competitiveness of the enterprise, with a total of 17 technical invention and creation and various product trademark patents. The company has transformed scientific and technological research and development achievements into social productivity, which is conducive to promoting the harmonious development of social economy in Guangxi. The continuous promotion and development of the company's "yuanantang" and "Fuyinjie" brands endow them with rich scientific and technological connotation and potential brand value. Due to the influence of the company's national medicine brand, the growth rate of market sales and the sense of identity of the majority of consumers. Guangxi yuanantang Pharmaceutical Co., Ltd. will, under the correct leadership of the party committees and governments at all levels in Guangxi Autonomous Region, under the careful guidance of Guangxi food and Drug Administration and the Forestry Department of Guangxi Autonomous Region, combine its own advantages, take the market as the guide, research and development as the driving force, benefit as the core, people-oriented, work hard, strengthen management, integrate resources, reform and innovation, and work hard, We will promote the development of local economy, build Guangxi's national brand of traditional Chinese medicine, and make further contributions to the development of traditional Chinese medicine and human health.

本文链接: https://brand.waitui.com/5f02b73e7.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

机构今日买入四方精创等20股,抛售哈尔斯5840万元

盘后数据显示,6月17日龙虎榜中,共40只个股出现了机构的身影,有20只股票呈现机构净买入,20只股票呈现机构净卖出。当天机构净买入前三的股票分别是四方精创、萃华珠宝、赢合科技,净买入金额分别是8497万元、5547万元、4747万元。当天机构净卖出前三的股票分别是哈尔斯、招商南油、信立泰,净流出金额分别是5840万元、5327万元、5184万元。

2小时前

刘强东谈首次退休:当时太理想主义了,想成为首个有职业经理人传承的互联网公司

京东集团董事局主席刘强东今日在一场分享会中谈及此前退休时表示,“第一次不是真正退休,当时还是太理想主义了”。刘强东表示,当时决定退出是因为觉得国内企业传承问题比较严重,所以当时自己就特别理想主义,想成为第一个大型的互联网公司中有职业经理人去传承,而不是自己非要干到八十多岁。所以觉得“该退休就退休,让年轻人上,而不要传给自己的孩子。”(新浪科技)

2小时前

达梦数据:上半年营业收入预计同比增长40.63%—45.74%

36氪获悉,达梦数据公告,截至目前,公司经营情况良好,据公司财务部门初步测算,公司1—6月预计实现营业收入4.95亿元—5.13亿元,较去年同期增长40.63%—45.74%。

2小时前

汇丰香港暂停为内地居民线下开立汇丰One账户?汇丰香港:消息不实

日前,部分社交媒体流传信息称,自2025年6月10日起,香港汇丰银行各分行已停止为内地居民线下办理“汇丰One”账户开户服务。从汇丰银行香港求证获悉,上述消息不实。汇丰香港发言人表示:“本行注意到网上流传关于在香港开立汇丰银行户口的不实讯息。汇丰继续欢迎内地客户申请开立户口。为确保客户取得最顺畅及舒适的体验,本行会不时审视服务流程和安排。我们同时鼓励客户通过香港汇丰流动理财应用程序开立汇丰One户口,以减少在分行的等待时间。”(财联社)

2小时前

多家基金公司将上报首批科创债ETF

从业内人士处获悉,易方达基金、华夏基金、广发基金、富国基金、嘉实基金、南方基金、博时基金、招商基金、景顺长城基金、鹏华基金10家基金公司即将上报首批科创债ETF。多家基金公司人士透露,目前正积极筹备相关产品的申报材料。今年以来,债券型ETF迎来跨越式发展。截至6月初,债券型ETF总规模突破3000亿元关口。科创债是指发行主体为科技创新领域相关企业或募集资金主要用于科技创新领域的债券。(中证网)

2小时前

本页详细列出关于肤阴洁的品牌信息,含品牌所属公司介绍,肤阴洁所处行业的品牌地位及优势。
咨询